Is measured GFR more accurate than eGFR for forecasting adverse outcomes?
Making an IMPACT on BP: Why pills alone won't win the war
This week we will discuss whether a bundled, team-based hypertension intervention- featuring intensive BP targets, home monitoring, health coaching, and audit feedback- can overcome poverty, clinical inertia, and fragmented care to improve blood pressure control in low-income patients receiving care at federally qualified health centers.
NephJC Short: Bayesian leash: How a prior walked the Tigris across the finish line
Why-dralazine?! Population risk of drug induced vasculitis
This week, we will discuss why a large registry cohort was needed to move past decades of scattered case reports and clarify the true risk of hydralazine‑associated vasculitis. When rare events hide in noise, only scale can reveal the signal. Can population‑level data finally bring this paradox into focus?
Live Blogging Trials from Conferences
Dialysis delay at what cost? Protein restriction as a distraction in the age of GDMT
A ray of hope APPEARS for C3G
Top Stories in Nephrology 2025
Dialysis deferred, logic recycled: BICAR ICU2
Kidney Week in Houston: Day 2
Kidney Week in Houston: Day 1
Empagliflozin, the kidney, and what we still don’t understand
Immune tolerance in kidney transplantation: from first principles to clinical engineering
Are E-Nudges Enough to Push Guideline-Based CKD Therapy?
Advance-HTN: Return of the systolic order – Lorundrostat’s role in restoring balance
Desmopresina intranasal: ¿previene el sangrado tras la biopsia renal en pacientes con enfermedad renal crónica?
Y no, no estás viendo doble… Doble dosis de desmopresina en #NephJC. El segundo estudio de Chakrabarti et al incluyó un escenario más complejo, aunque con resultados no concluyentes.
¿Será momento de replantear los estudios con desmopresina en la vida real?
No olvides revisar el resumen visual creado por Cristina Popa.
Patient with kidney disease under the knife: does desmopressin really plug the leak?
Can desmopressin reduce post-kidney biopsy bleeding? Visual abstract summarizing Kidney 360 article, by Cristina Popa
Double Trouble: ddAVP and the Bleeding Biopsy
Microvascular inflammation of kidney allografts
Microvascular inflammation from the perspective of a real unicorn: donor-specific antibodies with negative antibody mediated rejection 🦄
Metformina en la ERC avanzada
Un estudio observacional con emulación de ensayo aleatorizado en Escocia sugiere que mantener metformina en pacientes con ERC estadio 4 se asocia con mejor supervivencia y sin aumento de eventos cardiovasculares adversos mayores 🫀.
¿Estamos listos para replantear esta práctica?
Aquí te dejamos el resumen visual por Cristina Popa #NephJC
